E-LIB Suche - Ergebnisse für: Fernandez-Serra, A.

1

25P Prognostic classification of endometrial cancer accordi..:

Quispe, E.M. ; Lopez Reig, R. ; Fernandez-Serra, A....
ESMO Open. 8 (2023) 1 - p. 100796 , 2023

2

PCA3 as a second-line biomarker in a prospective controlled..:

Rubio-Briones, J. ; Casanova, J. ; Martínez, F....
Actas Urológicas Españolas (English Edition). 41 (2017) 5 - p. 300-308 , 2017

Link: https://doi.org/10.1016/..

3

315 Prospective randomized controlled study of the role of ..:

Rubio-Briones, J. ; Casanova, J. ; Dumont, R....
European Urology Supplements. 14 (2015) 2 - p. e315 , 2015

Link: https://doi.org/10.1016/..

4

External validation of FXYD3 and KRT20 as predictive biomar..:

Ramírez-Backhaus, M. ; Fernández-Serra, A. ; Rubio-Briones, J....
Actas Urológicas Españolas (English Edition). 39 (2015) 8 - p. 473-481 , 2015

Link: https://doi.org/10.1016/..

5

343 Optimizing use of PCA3 in initial prostate biopsy: Exte..:

Rubio, Briones J. ; Borque, A. ; Esteban, L....
European Urology Supplements. 13 (2014) 1 - p. e343 , 2014

Link: https://doi.org/10.1016/..

6

102 Involvement of TMPRSS2-ERG status and GSTP-1 expression..:

Fernandez-Serra, A. ; Rubio-Briones, J. ; Calatrava, A....
European Urology Supplements. 13 (2014) 1 - p. e102 , 2014

Link: https://doi.org/10.1016/..

7

Optimizing prostate cancer screening; prospective randomize..:

Rubio-Briones, J. ; Casanova, J. ; Dumont, R....
Actas Urológicas Españolas (English Edition). 38 (2014) 4 - p. 217-223 , 2014

Link: https://doi.org/10.1016/..

8

104 Loss of speckle-type POZ protein (SPOP) during prostate..:

Rubio, Briones J. ; Casanova-Salas, I. ; García-Flores, M....
European Urology Supplements. 13 (2014) 1 - p. e104 , 2014

Link: https://doi.org/10.1016/..

9

10 Prospective randomized controlled trial of the role of P..:

Rubio, Briones J. ; Casanova, J. ; Dumont, R....
European Urology Supplements. 12 (2013) 1 - p. e10-e11 , 2013

Link: https://doi.org/10.1016/..

10

Molecular Characterization and Clinical Impact ofTMPRSS2-ER..:

Fernández-Serra, A. ; Rubio, L. ; Calatrava, A....
BioMed Research International. 2013 (2013) - p. 1-10 , 2013

Link: https://doi.org/10.1155/..

11

856 Association of the Expression Profile of Prostate Cance..:

Fernandez-Serra, A. ; Rubio-Briones, J. ; Calatrava, A....
European Journal of Cancer. 48 (2012) - p. S206 , 2012

Link: https://doi.org/10.1016/..

12

428 Involvement of molecular factors in the prognosis of pr..:

Rubio-Briones, J. ; Fernandez-Serra, A. ; Calatrava, A....
European Urology Supplements. 11 (2012) 1 - p. e428-e428a , 2012

Link: https://doi.org/10.1016/..

13

P051 Prospective randomized controlled trial of the role of..:

Rubio-Briones, J. ; Casanova, J. ; Domínguez-Escrig, J....
European Urology Supplements. 11 (2012) 5 - p. 207 , 2012

Link: https://doi.org/10.1016/..

14

541 MiRNA profiling in the screening of potential biomarker..:

Rubio-Briones, J. ; Fernandez-Serra, A. ; Casanova-Salas, I....
European Urology Supplements. 11 (2012) 1 - p. e541-e541a , 2012

Link: https://doi.org/10.1016/..

15

819 MiRNA Profiling in the Screening of Potential Biomarker..:

Casanova-Salas, I. ; Rubio-Briones, J. ; Fernandez-Serra, A....
European Journal of Cancer. 48 (2012) - p. S196 , 2012

Link: https://doi.org/10.1016/..